$STX

MOSLEY WILLIAM D sold $8.6M of STX

MOSLEY WILLIAM D (CEO) sold 9,343 shares of Seagate Technology Holdings plc (STX) at an average of $924.42 ($919.64–$936.36, $8.64M total) across 15 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MOSLEY WILLIAM D
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
high confidence
Mentioned
$STX
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

The disclosed event is an open-market sale by the CEO, pre-arranged under Rule 10b5-1, totaling about $8.64M across 15 trades.

02

Market read

Traders may monitor insider activity for sentiment, but this specific filing does not introduce new company fundamentals or a discrete catalyst.

03

What to watch

Because the trades are under a 10b5-1 plan, the sale timing is mechanically scheduled and may not reflect new negative information; also, the filing does not state whether other insiders are buying or selling concurrently.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-02 for trades dated 2026-07-01

Background

The article is a SEC Form 4 insider transaction disclosure for Seagate Technology Holdings plc (STX).

Company-level read

Ticker impact

$STXNeutralHigh confidence
Context

Seagate CEO William D. Mosley sold about 9,343 shares in open-market trades for roughly $8.64M under a 10b5-1 plan.

Expected impact

Near-term impact likely limited; any effect would be incremental sentiment around insider selling rather than a new catalyst.

Evidence & confidence

The filing is a Form 4 open-market sale executed under a pre-arranged Rule 10b5-1 plan, with no accompanying guidance, deal, or regulatory action disclosed in the text.

Market effects

Limited read-through to the storage/tech hardware sector because the disclosure is an individual insider transaction, not a company event.

None indicated.

None indicated.

Counterpoint

Insider sales can still signal valuation or liquidity needs, and traders may front-run additional selling if multiple executives file similar Form 4s soon.

Key entities

  • Seagate Technology Holdings plc

    Subject of the Form 4 insider transaction disclosure.

  • MOSLEY WILLIAM D

    CEO and reporting person who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.